UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Identifying which cash back cards are worth it can enhance your financial strategy. Explore the top options for maximizing rewards.
25,607 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
An insider sale at AGCO raises questions about the agricultural machinery cycle. This article breaks down what what t...
Two clean-energy names. One clear question: which has the better odds of delivering big returns for investors over th...
Rocket Lab has surged on new contracts and a growing backlog, yet investors wonder if the rally can last. This guide ...
Thomson Reuters stock crushed expectations on Monday as AI announcements sparked momentum. This guide breaks down wha...
Nu Holdings is poised for a volatile after-hours session as it reports quarterly results. Analysts weigh margin gains...
D-Wave Quantum stock is rallying on recent funding news and government support. This guide breaks down what that mean...
As AI accelerates, Greg Abel is steering Berkshire Hathaway Energy to prepare for higher data-center electricity dema...
Investors sent Joby Aviation stock higher after the company topped expectations on its latest results. This article b...
GameStop is targeting a larger authorized share count to keep financing options flexible. This move sparks questions ...
Alphabet's Gemini delays raise questions about AI leadership and stock resilience. This guide analyzes what the lag m...
Last year, a surprising shift reshaped the housing market: more than 60% of buyers bought below asking price, marking...